文献速递外周血管腹部介入CTDSA

急性动脉性肠系膜缺血的血管内血运重建:来自肠卒中中心单元3年经验报告

Endovascular revascularization of acute arterial mesenteric ischemia: report of a 3-year experience from an intestinal stroke center unit.
PubMed 文献 · Eur Radiol · 2022-03-08

该研究报告了肠卒中中心单元3年间收治的58例急性动脉性肠系膜缺血患者接受血管内血运重建的前瞻性数据回顾分析,技术成功率为88%,术后并发症发生率为17%,3个月、1年、3年生存率分别为79%、78%和63%,结论认为血管内血运重建高度可行且并发症率可接受,但须作为多学科患者管理策略的一部分来解读。

要点

  • 血管内血运重建治疗急性动脉性肠系膜缺血技术成功率高(88%),并发症率可接受(17%)。
  • 术后55%患者无需进一步治疗,16%行二期肠切除,9%行外科血运重建,9%两者均行。
  • 3个月、1年、3年生存率分别为79%、78%、63%,不同治疗路径及基线特征间生存无显著差异。

核心结论

  • 血管内血运重建治疗急性动脉性肠系膜缺血高度可行,并发症率可接受;其结果应仅作为多学科患者管理策略的一部分来解读。

研究设计与样本

  • 肠卒中中心单元单中心前瞻性采集数据并回顾性分析,纳入2016年1月至2019年1月间因动脉性急性肠系膜缺血接受血管内再通治疗的58例患者(男34例[59%],平均年龄69±29岁),复习患者人口学、临床和实验室特征及CT扫描,记录血管内操作类型(溶栓、取栓、支架置入)和结局(技术成功或失败、并发症),描述术后治疗路径(外科血运重建、肠切除)并评估亚组死亡率。

诊断标准与关键数值

  • 血管内血运重建技术成功51/58例(88%),术后并发症10例(17%)。
  • 支架置入33例、原位溶栓19例为多数患者采用的血管内技术。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: To report the 3-year experience of endovascular revascularization of acute arterial mesenteric ischemia (AMI) from an intestinal stroke center unit (ISCU).

METHOD: All data from patients admitted to the ISCU between January 2016 and January 2019 for arterial AMI who underwent endovascular recanalization were prospectively acquired and retrospectively analyzed. Patient demographics, clinical and laboratory characteristics at presentation, and CT scans were reviewed. The type (thrombolysis, thrombectomy, stenting) and the outcome of endovascular procedures (technical success or failure, complications) were noted. Care pathways were described focusing on post-procedural treatments (surgical revascularization, bowel resection) and the mortality rate was evaluated in subgroups.

RESULTS: Fifty-eight patients (34 men [59%], mean 69 ± 29 years) were included. Endovascular revascularization was technically successful in 51/58 (88%) patients, and 10 (17%) patients had post-procedural complications. Stenting and in situ thrombolysis were performed in most patients (n = 33 and n = 19, respectively). Thirty-two patients (55%) were recurrence-free and required no further treatment after the procedure, while 9 (16%), 5 (9%), and 5 (9%) patients underwent 2nd-line bowel resection, surgical revascularization, or both. Overall, 46 (79%), 45 (78%), and 34 patients (63%) were alive at 3 months, 1 year, and 3 years. No significant difference in survival was found in care pathways or baseline characteristics.

CONCLUSION: Endovascular revascularization is highly feasible for the treatment of arterial AMI, and is associated with an acceptable rate of complications. Results of endovascular revascularization shall only be interpreted as part of a multidisciplinary patient management strategy.

KEY POINTS: • Endovascular revascularization is highly feasible for the treatment of arterial AMI, and is associated with an acceptable rate of complications. • Several techniques are available to perform endovascular revascularization, and their use depends on the cause, the location, and the quality of underlying arteries of patients. • Results of endovascular revascularization shall only be interpreted in relation to its role in an integrated multidisciplinary and patient management strategy.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Najdawi, Garzelli, Nuzzo, et al. Endovascular revascularization of acute arterial mesenteric ischemia: report of a 3-year experience from an intestinal stroke center unit. Eur Radiol. 2022. PMID: 35258671. doi:10.1007/s00330-022-08660-3

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。